Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases

Fig. 3

Comparison of intracranial progression-free survival (PFS) (A) and local tumour control (LTC) (B) for WBRT and WBRT + SIB in non-small cell lung cancer patients (NSCLC) using competing risk analyses. Comparison of intracranial PFS (C) and LTC (D) for WBRT and WBRT + SIB in small cell lung cancer (SCLC) patients using competing risk analyses. Landmark analysis of intracranial PFS (E) and LTC (F) in SCLC patients receiving WBRT + SIB and WBRT (cutoff time = 5 months)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us